XTL Biopharmaceuticals Price Chart
XTL Biopharmaceuticals Volume Chart
XTL Biopharmaceuticals Market Segments
After Hours
+0.00(+0.00%)
| Open | $2.13 |
|---|---|
| Close | $2.13 |
| Low | $2.13 |
| Low Change | 0.00 (0.00%) |
| High | $2.13 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 788 |
| Dollar Volume | $1.68K |
Regular Trading Hours
-0.04(-1.80%)
| Open | $2.22 |
|---|---|
| Close | $2.18 |
| Low | $2.12 |
| Low Change | -0.10 (-4.50%) |
| High | $2.39 |
| High Change | +0.17 (+7.66%) |
| Range | $0.27 |
| Volume | 6.868K |
| Dollar Volume | $14.97K |
Premarket
*No Trades in Segment
After Hours Yesterday
-0.01(-0.42%)
| Open | $2.29 |
|---|---|
| Close | $2.28 |
| Low | $2.28 |
| Low Change | -0.01 (-0.42%) |
| High | $2.29 |
| High Change | +0.00 (+0.00%) |
| Range | $0.01 |
| Volume | 899 |
| Dollar Volume | $2.05K |
Regular Trading Hours Yesterday
+0.03(+1.30%)
| Open | $2.31 |
|---|---|
| Close | $2.34 |
| Low | $2.28 |
| Low Change | -0.03 (-1.30%) |
| High | $2.43 |
| High Change | +0.12 (+5.31%) |
| Range | $0.15 |
| Volume | 3.717K |
| Dollar Volume | $8.70K |
Premarket Yesterday
+0.03(+1.28%)
| Open | $2.35 |
|---|---|
| Close | $2.38 |
| Low | $2.35 |
| Low Change | 0.00 (0.00%) |
| High | $2.38 |
| High Change | +0.03 (+1.28%) |
| Range | $0.03 |
| Volume | 706 |
| Dollar Volume | $1.68K |
XTL Biopharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $2.28 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.31 |
| 20 Day Moving Average (SMA20) | $2.42 |
| 50 Day Moving Average (SMA50) | $2.60 |
| 100 Day Moving Average (SMA100) | $1.79 |
| 200 Day Moving Average (SMA200) | $1.42 |
XTL Biopharmaceuticals Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
XTL Biopharmaceuticals Stock Splits
There have been 2 stock splits for XTL Biopharmaceuticals (XTLB). The last reverse stock split occured on March 25, 2026 and reduced the outstanding shares at a ratio of 4:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 25, 2026 | Reverse | 4:1 |
| Feb 10, 2017 | Reverse | 5:1 |
XTL Biopharmaceuticals Dividends
There have been no dividends for XTL Biopharmaceuticals (XTLB).